D. Jody

3.4k citations

23 papers · 1.6k indexed · h-index 14

Impact in

Psychiatry and Mental health top 1%
- Schizophrenia research and treatment
- Bipolar Disorder and Treatment
Biological Psychiatry top 5%

Papers in ⓘ

Psychiatry and Mental health 15
- Schizophrenia research and treatment 13
- Bipolar Disorder and Treatment 5
Pharmacology 4
- Treatment of Major Depression 4

Co-authors: William H. Carson (6 shared papers)Jeffrey A. Lieberman (4 shared papers)Robert D. McQuade (5 shared papers)José Alvir (3 shared papers)S. Szymanski (4 shared papers)S. Geisler (2 shared papers)David Mayerhoff (3 shared papers)Д. Арчибалд (3 shared papers)
Journals: European Neuropsychopharmacology (6 papers)Schizophrenia Research (4 papers)Neurology (2 papers)JAMA (1 paper)Biological Psychiatry (1 paper)
Partner nations: United States Germany United Kingdom

In The Last Decade

D. Jody

23 papers receiving 1.6k citations

Peers

Countries citing papers authored by D. Jody

Since Specialization

Citations

This map shows the geographic impact of D. Jody's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. Jody with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. Jody more than expected).

Fields of papers citing papers by D. Jody

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D. Jody. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. Jody. The network helps show where D. Jody may publish in the future.

Co-authors

The 25 scholars most cited alongside D. Jody, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with D. Jody Line = papers co-authored together D. Jody links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 23 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Gender differences in onset of illness, treatment response, course, and biologic indexes in first-episode schizophrenic patients American Journal of Psychiatry ·S. Szymanski, Jeffrey A. Lieberman, José Alvir, David Mayerhoff, A. Loebel, S. Geisler, Miranda Chakos, A. Koreen, D. Jody, John M. Kane	1995	255
2	Alemtuzumab CARE-MS II 5-year follow-up Neurology ·Alasdair Coles, Jeffrey Cohen, Edward Fox, Gavin Giovannoni, Hans‐Peter Hartung, Eva Havrdová, Sven Schippling, Krzysztof Selmaj, Anthony Traboulsee, D. A. S. Compston, David Margolin, Karthinathan Thangavelu, Madalina Chirieac, D. Jody, Panos Xenopoulos, Richard Hogan, Michael Panzara, Douglas L. Arnold	2017	212
3	Switching patients to aripiprazole from other antipsychotic agents: a multicenter randomized study Psychopharmacology ·(unknown), Daniel E. Casey, William H. Carson, Anutosh Ranjan Saha, Amy Liebeskind, Mirza W. Ali, D. Jody, Г. Ингенито	2003	207
4	A comparison of weight change during treatment with olanzapine or aripiprazole: results from a randomized, double-blind study. PubMed ·Robert D. McQuade, Elyse Stock, R.N. Marcus, D. Jody, Neveen A. Gharbia, Simon Vanveggel, Д. Арчибалд, William H. Carson	2004	195
5	Alemtuzumab CARE-MS I 5-year follow-up Neurology ·Eva Havrdová, Douglas L. Arnold, Jeffrey Cohen, Hans‐Peter Hartung, Edward Fox, Gavin Giovannoni, Sven Schippling, Krzysztof Selmaj, Anthony Traboulsee, D. A. S. Compston, David Margolin, Karthinathan Thangavelu, Claudio E. Rodriguez, D. Jody, Richard Hogan, Panos Xenopoulos, Michael Panzara, Alasdair Coles	2017	176
6	Anterior hippocampal volume reductions predict frontal lobe dysfunction in first episode schizophrenia Schizophrenia Research ·Robert M. Bilder, B. Bogerts, Manzar Ashtari, Houwei Wu, José Alvir, D. Jody, G. Reiter, Lisa Bell, Jeffrey A. Lieberman	1995	159
7	Self-Reported Depressive Symptom Measures: Sensitivity to Detecting Change in a Randomized, Controlled Trial of Chronically Depressed, Nonpsychotic Outpatients Neuropsychopharmacology ·A. John Rush, Madhukar H. Trivedi, Thomas Carmody, Hisham M. Ibrahim, John C. Markowitz, Gabor I. Keitner, Susan G. Kornstein, Bruce A. Arnow, Daniel N. Klein, Rachel Manber, David L. Dünner, Alan J. Gelenberg, James H. Kocsis, Charles B. Nemeroff, Jan Fawcett, Michael E. Thase, James M. Russell, D. Jody, Frances E. Borian, Martin B. Keller	2004	107
8	Reemergence of Sexual Dysfunction in Patients With Major Depressive Disorder The Journal of Clinical Psychiatry ·James M. Ferguson, Ram Shrivastava, Stephen M. Stahl, James T. Hartford, Frances E. Borian, John R. Ieni, Robert D. McQuade, D. Jody	2001	83
9	Methylphenidate increases thought disorder in recent onset schizophrenics, but not in normal controls Biological Psychiatry ·Deborah L. Levy, Melissa J. Smith, Delbert G. Robinson, D. Jody, Gail Lerner, José Alvir, Stephen Geisler, S. Szymanski, Alberto González-Aguilar, David Mayerhoff, Jeffrey A. Lieberman, Nancy R. Mendell	1993	39
10	Treatment outcome of first episode schizophrenia. PubMed ·J.A. Lieberman, D. Jody, S. Geisler, J Vital-Herne, JM Alvir, Joyce A. Walsleben, Woerner Mg	1989	36
11	Validation of the Investigator's Assessment Questionnaire, a new clinical tool for relative assessment of response to antipsychotics in patients with schizophrenia and schizoaffective disorder Psychiatry Research ·Rajiv Tandon, Robert F. DeVellis, Jian Han, Hong Li, Sophia Frangou, Serdar Dursun, J.N. Beuzen, William H. Carson, Patricia K. Corey‐Lisle, Bruno Falissard, D. Jody, Mary J. Kujawa, Gilbert L’Italien, Ronald N. Marcus, Robert D. McQuade, Saurabh Ray, Pascal Van Peborgh	2005	33
12	Behavioral response to methylphenidate and treatment outcome in first episode schizophrenia. PubMed ·D. Jody, J.A. Lieberman, S. Geisler, S. Szymanski, José Alvir	1990	25
13	Normal eye tracking is associated with abnormal morphology of medial temporal lobe structures in schizophrenia Schizophrenia Research ·Deborah L. Levy, B. Bogerts, Gustav Degreef, Beth Dorogusker, Christine Waternaux, Manzar Ashtari, D. Jody, Stephen Geisler, Jeffrey A. Lieberman	1992	15
14	Meta-analysis of weight effects with aripiprazole European Neuropsychopharmacology ·D. Jody, Aditi Saha, T. Iwamoto, D.R. Biswas, Chin‐Yo Lin, Robert Marcus, Rachel M. McQuade	2002	15
15	Aripiprazole versus placebo in acute mania European Neuropsychopharmacology ·R. Marcus, A.R. Saha, D. Jody, Stavros Tourkodimitris, Д. Арчибалд, Takashi Iwamoto	2002	13
16	Switching to aripiprazole monotherapy Schizophrenia Research ·M. Kujawa, A.R. Saha, Mirza W. Ali, D. Jody, Robert D. McQuade, Г. Ингенито	2003	10
17	P.2.108 Plasma lipids levels and glycemic control in long-term treatment with aripiprazole European Neuropsychopharmacology ·Eveline O. Stock, S.R. Marder, D. Jody, Stephen Kaplita, Achintya Saha, William H. Carson, A. Torbeyns	2003	8
18	P.2.111 Long-term effects of aripirazole on the negative symptoms of schizophrenia European Neuropsychopharmacology ·Dušan Kostić, George Manos, Elyse Stock, D. Jody, Д. Арчибалд, Stavros Tourkodimitris, R. Marcus	2003	7
19	P.2.105 Efficacy and safety of aripiprazole versus perphenazine in treatment-resistant schizophrenia European Neuropsychopharmacology ·Robert D. McQuade, D. Jody, John M. Kane, William H. Carson, M. Kujawa, Joseph Stringfellow, R. Marcus, Raymond Sanchez, H.Y. Meltzer	2003	7
20	Alemtuzumab CARE-MS II 5-year follow-up Apollo (University of Cambridge) ·Alasdair Coles, JA Cohen, E. Long Fox, Gavin Giovannoni, HP Hartung, Eva Havrdová, Sven Schippling, Krzysztof Selmaj, Anthony Traboulsee, Alastair Compston, DH Margolin, Kruthika Thangavelu, MC Chirieac, D. Jody, Panos Xenopoulos, RJ Hogan, MA Panzara, Douglas L. Arnold	2017	6

About D. Jody

D. Jody is a scholar working on Psychiatry and Mental health, Pharmacology, Neurology, Physiology and Pathology and Forensic Medicine, having authored 23 papers that have together received 1.6k indexed citations. Recurring topics across this work include Schizophrenia research and treatment (13 papers), Bipolar Disorder and Treatment (5 papers), Treatment of Major Depression (4 papers), Mental Health and Psychiatry (2 papers), Parkinson's Disease Mechanisms and Treatments (2 papers), Health Systems, Economic Evaluations, Quality of Life (2 papers), Diet and metabolism studies (2 papers) and Multiple Sclerosis Research Studies (2 papers). The work is most often cited by research in Psychiatry and Mental health (922 citations), Biological Psychiatry (80 citations), Pathology and Forensic Medicine (342 citations), Philosophy (173 citations) and Neurology (204 citations). D. Jody has collaborated with scholars based in United States, Germany and United Kingdom. Frequent co-authors include William H. Carson, Jeffrey A. Lieberman, Robert D. McQuade, José Alvir, S. Szymanski, S. Geisler, David Mayerhoff, Д. Арчибалд, Mirza W. Ali and Г. Ингенито. Their work appears in journals such as European Neuropsychopharmacology, Schizophrenia Research, Neurology, JAMA and Biological Psychiatry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact